Sensing Tumor Microenvironments
DNA nanobots are engineered to detect the unique chemical signals present within tumor microenvironments. These signals—such as low pH, hypoxia, or specific enzymes—differ from those in healthy tissues. By sensing these cues, nanobots can activate only when they reach cancerous areas, ensuring even greater targeting precision. This responsive behavior not only enhances therapeutic effectiveness but also minimizes off-target effects, making DNA nanobots an intelligent and adaptive tool for cancer treatment.